Drug Target Review2024-06-14T12:00:20
The novel drug, ETD001, could provide an improved approach for mucus clearance in cystic fibrosis patients.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-18T11:12:00Z
2026-11-18T07:00:00Z
Contributor Dr Bryan McClellan and Dr William Matsui, Drug Target Review
2026-11-16T07:00:00Z
Author Dr Martin Baraibar
2026-10-26T06:23:00
Author Amine Bouchareb
2026-11-11T14:00:00
Sponsored by Cell Signaling Technology
2026-06-02T15:00:00
Sponsored by Danaher
2026-09-22T07:00:00
Contributor Luca Lotta, Drug Target Review
2026-08-24T08:43:00
Author Dr Dana Watt
Site powered by Webvision Cloud